Differences
This shows you the differences between two versions of the page.
|
start [2020/01/08 00:17] dkreil |
start [2020/06/05 00:38] (current) plabaj |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== Celebrate with us – CAMDA 2000-2020! ====== | + | ====== CAMDA 2020 Conference ====== |
| - | /** ====== CAMDA 2020 Conference ====== | ||
| - | */ | ||
| \\ | \\ | ||
| **CAMDA** runs in collaboration with [[https://www.iscb.org/ismb2020|ISMB]]. **CAMDA** is now an established full conference track at ISMB, representing one of its Communities of Special Interests (COSIs). This gives you wide exposure and further opportunities for interaction with colleagues without separate registration fees. You just register for a 2- or 4-day ticket at ISMB, specifying **CAMDA** as your interest.\\ | **CAMDA** runs in collaboration with [[https://www.iscb.org/ismb2020|ISMB]]. **CAMDA** is now an established full conference track at ISMB, representing one of its Communities of Special Interests (COSIs). This gives you wide exposure and further opportunities for interaction with colleagues without separate registration fees. You just register for a 2- or 4-day ticket at ISMB, specifying **CAMDA** as your interest.\\ | ||
| Line 12: | Line 10: | ||
| * The **Hi-Res Cancer Data Integration Challenge** presents clinical and matched molecular profiles, with read level data for individual genomes. Explore non-standard genomes and splicing events for better prognosis. /* in a range of cancers (breast, kidney, neck, lung). */ | * The **Hi-Res Cancer Data Integration Challenge** presents clinical and matched molecular profiles, with read level data for individual genomes. Explore non-standard genomes and splicing events for better prognosis. /* in a range of cancers (breast, kidney, neck, lung). */ | ||
| * The **CMap Drug Safety Challenge** presents clinical toxicity results, cellular and molecular responses to hundreds of drugs. Compare and integrate a range of cell line assays to predict the severity of the drug induced liver injury in humans. /*from cell expression and imaging assays extended by chemical structures.*/ | * The **CMap Drug Safety Challenge** presents clinical toxicity results, cellular and molecular responses to hundreds of drugs. Compare and integrate a range of cell line assays to predict the severity of the drug induced liver injury in humans. /*from cell expression and imaging assays extended by chemical structures.*/ | ||
| - | * The **Metagenomic Geolocation Challenge** presents thousands of city microbiome profiles in context of climate data. Construct multi-source microbiome fingerprints and predict the ecological niche or exact geographical origin of mystery samples. | + | * The **Metagenomic Geolocation Challenge** presents thousands of city microbiome profiles in the context of climate data. Construct multi-source microbiome fingerprints and predict the ecological niche or exact geographical origin of mystery samples. |
| Leading scientists present their best methods and analyses in talks, complemented by poster sessions. **Papers** based on the [[call_for_papers|submitted]] extended abstracts are published in the open access, fully indexed [[http://www.biomedcentral.com/collections/camda|conference proceedings]] at //[[https://biologydirect.biomedcentral.com/|Biology Direct]]//. | Leading scientists present their best methods and analyses in talks, complemented by poster sessions. **Papers** based on the [[call_for_papers|submitted]] extended abstracts are published in the open access, fully indexed [[http://www.biomedcentral.com/collections/camda|conference proceedings]] at //[[https://biologydirect.biomedcentral.com/|Biology Direct]]//. | ||
| Line 25: | Line 23: | ||
| \\ | \\ | ||
| - | We cordially invite you to attend and contribute to **CAMDA**, and look forward to seeing you this year in **Montreal!** \ \ (//Travel fellowships// available) | + | We cordially invite you to attend and contribute to **CAMDA**, and look forward to seeing you this year **virtually!** \ \ (//Fellowships// available) |
| \\ | \\ | ||
STAY CONNECTED
Tweet